Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (437)

431

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies : A Possible Treatment for Severe Cases of COVID-19

enthalten in: Drug design, development and therapy | 2020

von Sedokani, A. | Feizollahzadeh, S.

432

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection : implications for therapy

enthalten in: mAbs | 2020

von Miao, X. | Luo, Y. | Huang, X. | +26

433

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity : Implications for the Design of Spike-Based Vaccine Immunogens

enthalten in: Frontiers in immunology | 2020

von Duan, L. | Zheng, Q. | Zhang, H. | +3

434

Virological and Serological Discordant Profiles in COVID-19 Pneumonia : Two Atypical Clinical Cases

enthalten in: Frontiers in immunology | 2020

von Ranzenigo, M. | Pastori, C. | Siracusano, G. | +3

435

Mucosal Immunity in COVID-19 : A Neglected but Critical Aspect of SARS-CoV-2 Infection

enthalten in: Frontiers in immunology | 2020

von Russell, M. | Moldoveanu, Z. | Ogra, P. | +1

436

Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)

enthalten in: Frontiers in immunology | 2020

von Kim, D. | Rowland-Jones, S. | Gea-Mallorquí, E.

437

Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension

enthalten in: Frontiers in immunology | 2020

von Zeng, Q. | Li, Y. | Dong, S. | +5

[1]
« Vorheriger
34
35
36
37
38
39
40
41
42
43
44